Trustees’ Annual Report for the period
From 1[st] January 2021 Period start date To Period end date
31[st] December 2021
Charity name: Cure CLCN4 LTD
Charity registration number: 1190344
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | Cure CLCN4 Limited is a not-for-profit organisation constituted with charitable purposes in perpetuity. The company is limited by guarantee and is governed by a memorandum and articles of association. The objectives of Cure CLCN4 Limited are: a) The advancement of health, relief of sickness and saving of lives by such means as the trustees see fit including but not exclusively through: i) Providing relief and assistance to people suffering from pathogenic variants of clcn4; and ii) The funding of medical research anywhere in the world for the purpose of discovering, developing and delivering treatment for patients with pathogenic variants of clcn4; and B) The furtherance of such other charitable purpose or charitable purposes as the trustees in their absolute discretion from time-to-time think fit, in each case for the public benefit. |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
The Charity's objects are such exclusively charitable objects and purposes for the public benefit throughout England and Wales as the trustees may in their discretion think fit. The Charity furthers its charitable purposes for the benefit of the public by funding or undertaking scientific research for the advancement of knowledge of clcn4 related condition and by supporting those affected by it. |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | The trustees have due regard to the Charity Commission's guidance as to operation of the public benefit requirement when exercising powers or duties to which the guidance is relevant and in their opinion the charity's activities are wholly for the benefit of the public. |
Additional information (optional) You may choose to include further statements where relevant about:
SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment
Para 1.38 Contribution made by volunteers Other
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | Cure CLCN4 LTD has successfully initiated projects for the generation/validation of important tools for the furthering of scientific research into CLCN4 condition (including an animal model as well as the first official registry for CLCN4 patients) We have worked on supporting affected families via the provision of accessible and up-to-date information on CLCN4 condition on our website as well as via the organisation of the first Cure CLCN4 Family Meeting. Hiring of a full-time research manager to ensure the continuity and progress of our activities towards the objectives of the charity. |
Additional information (optional) You may choose to include further statements where relevant about:
| Achievements against objectives set |
Para 1.41 | |
| Performance of fundraising activities against objectives set |
Para 1.41 | |
| Investment performance against objectives |
Para 1.41 | |
| Other |
Financial Review
| Review of the charity’s financial position at the end of the period |
Para 1.21 | The charity’s financial position at the end of 2021 is healthy with a balance of GBP 65.5k. This is the first year that the charity has an income. This revenue has allowed us to support the charity’s projects in the furtherance of our objectives including research and support of affected families and leaves us with enough reserves to carry out more and larger projects on the following year. |
|---|---|---|
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | The trustees aim to maintain reserves at a level which equates to approximately six months of charitable expenditure. The trustees consider that this level will provide sufficient funds to project and operational need and ensure that support and governance costs are covered. The trustees consider that a level of 6 months is sufficient. |
| Amount of reserves held | Para 1.22 | £65,562 |
| Reasons for holding zero reserves |
Para 1.22 | N/A |
| Details of fund materially in deficit |
Para 1.24 | N/A |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | No uncertainties. |
Additional information (optional) You may choose to include further statements where relevant about:
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | |
|---|---|---|
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | |
| A description of the principal risks facing the charity |
Para 1.46 | |
| Other |
Structure, Governance and Management
| Description of charity’s trusts: |
||
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | Memorandum and Articles Incorporated 06 Feb 2020 |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | Charitable company (limited by guarantee) |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | The Board shall be permitted to appoint by majority decision any individual who is eligible as a Trustee to fill a vacancy in their number or as an additional Trustee. |
Additional information (optional) You may choose to include further statements where relevant about:
| Policies and procedures adopted for the induction and training of trustees |
Para 1.51 | |
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | |
| Relationship with any related parties |
Para 1.51 | |
| Other |
Reference and Administrative details
| Charity name | Cure CLCN4 LTD |
|---|---|
| Other name the charity uses | |
| Registered charity number | 1190344 |
| Charity’s principal address | 2 Duke Street London W1U 3EH |
Names of the charity trustees who manage the charity
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Trustee name | Office (if any) | Dates acted if not for whole **year ** |
Name of person (or body) entitled to appoint trustee (ifany) |
|---|---|---|---|---|
| Peter James Alistair Trill |
||||
| Larry Louison | ||||
| Alan Wise | ||||
| Wang Sin Tan | ||||
| Alexis Karim | ||||
| Paul McGuinness | June 2022 - present | |||
– Corporate trustees names of the directors at the date the report was approved
Director name Peter James Alistair Trill Larry Louison Alan Wise Wang Sin Tan Alexis Karim Paul McGuinness
Name of trustees holding title to property belonging to the charity
Trustee name Dates acted if not for whole year
Funds held as custodian trustees on behalf of others
| Description of the assets held in this capacity |
N/A |
|---|---|
| Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects |
N/A |
| Details of arrangements for safe custody and segregation of such assets from the charity’s own assets |
N/A |
Additional information (optional)
Names and addresses of advisers (Optional information)
| Type of | Name | Address |
|---|---|---|
| adviser |
Name of chief executive or names of senior staff members (Optional information)
Exemptions from disclosure
Reason for non-disclosure of key personnel details
Other optional information
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s) Full name(s) Peter James Alistair Trill Position (eg Secretary, Trustee Chair, etc) Date 26/10/2022
CURE CLCN4 (a company limited by guarantee)
Financial Statements for the period ended 31 December 2021
Company Number: 12447230
CURE CLCN4 (a company limited by guarantee)
Statement of accounts for the period ended 31 December 2021
Contents
| Page | |
|---|---|
| 1 | Legal and administrative information |
| 2 -3 | Directors’ report |
| 4 | Statement of financial activities for the period ended 31 December 2021 |
| 5 | Balance sheet as at 31 December 2021 |
| 6-8 | Notes to the accounts |
CURE CLCN4 (a company limited by guarantee)
Legal and administrative information
Governed by
Memorandum and Articles of Association dated 6 February 2020.
Directors
P Trill A Karim W Tan A Wise L Louison Paul McGuinness (Appointed 7 June 2022)
Registered Office
2 Duke Street London W1U 3EH
Accountants
TC Group Level One Devonshire House One Mayfair Place London W1J 8AJ
Registered charity number
1190344
Company Number
12447230
1
CURE CLCN4 (a company limited by guarantee)
Directors’ Report
The Directors’ submit the organisations report for the period ended 31 December 2021.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The organisation is a charitable company limited by guarantee. The company was established under a memorandum of Association which sets out the objects and powers of the charitable company and is governed under its Articles of Association.
Recruitment, Appointment and Training of Trustees
Trustees can be nominated by any member of the Board of the Trustees to replace a trustee stepping down.
Appointment of newly nominated Trustees requires unanimous approval of all Trustees.
The new Trustee is provided with details of Trustees’ roles and responsibilities. Training as such is not provided as no one has felt it to be necessary. At meetings, there is always room for questions and explanations.
OBJECTIVES AND ACTIVITIES
Charitable Objectives
Cure CLCN4 Limited is a not for profit organisation constituted with charitable purposes in perpetuity. The company is limited by guarantee and is governed by a memorandum and articles of association.
The objectives of Cure CLCN4 Limited are:
-
A) The advancement of health, relief of sickness and saving of lives by such means as the trustees see fit including but not exclusively through:
-
i) Providing relief and assistance to people suffering from pathogenic variants of clcn4; and
-
ii) The funding of medical research anywhere in the world for the purpose of discovering, developing and delivering treatment for patients with pathogenic variants of clcn4; and
-
B) The furtherance of such other charitable purpose or charitable purposes as the trustees in their absolute discretion from time to time think fit, in each case for the public benefit.
FINANCIAL REVIEW
This is the second year of operations, and the focus has been on continuing to build out and consolidate the infrastructure of the charity. Further, in line with the charity objectives we have organised events to support families and connect with the research community as well as worked on developing essential research tools such as an animal model and patient registry.
2
CURE CLCN4 (a company limited by guarantee)
Directors’ Report (continued)
STATEMENT OF DIRECTORS’ RESPONSIBILITIES
The Directors’ are required under company law to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law Directors’ must not approve the financial statements unless they are satisfied that they give a true and fair view of the company and of the surplus or deficit of the company for that period. In preparing those financial statements the Directors’ are required to:
-
a) Select suitable accounting policies and then apply them consistently;
-
b) Observe the methods and principles in the Charities SORP;
-
c) Make judgements and estimates that are reasonable and prudent;
-
d) State whether applicable UK accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;
-
e) Prepare the financial statements on a going concern basis unless it is inappropriate to presume that the company will continue in operation.
The Directors’ are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the requirements of the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The above report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.
On behalf of the Directors
----- Start of picture text -----
…………………………………..
----- End of picture text -----
Mr P Trill Director Date: 25/10/22
3
CURE CLCN4 (a company limited by guarantee)
Combined Statement of Financial Activities and Income Statement for the period ended 31 December 2021
| Note INCOME FROM Donations 3 Other income Total Income EXPENDITURE ON Charitable activities Administration 4 Total expenditure Net incoming/(outgoing) resources Total funds brought forward Total funds at 31 December 2021 |
Restricted £ |
2021 Unrestricted £ 107,720 - 107,720 - 33,610 33,098 74,110 (8,548) 65,652 |
Total £ - - - - |
2020 Total £ - - - - 8,548 8,548 (8,548) - (8,548) |
|---|---|---|---|---|
The statement of financial activities includes all gains and losses in the year. All incoming resources and resources expended derive from continuing activities.
4
CURE CLCN4 (a company limited by guarantee)
Balance sheet as at 31 December 2021
| Note Current Assets Cash at bank and in hand 5 Debtors 6 Total assets Creditors: Amounts falling due within one year 7 Net Current Assets Total Assets Less Current Liabilities Funds Unrestricted funds |
2021 £ £ 77,628 2,120 79,748 (14,186) 65,562 65,562 65,562 **65,562 ** |
2020 £ 2,890 (11,438) (8,548) (8,548) (8,548) (8,548) |
|---|---|---|
For the financial period ended 31 December 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006. The members have not required the company to obtain an audit of these financial statements pursuant to section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with Section 368 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its surplus or deficit for the financial period in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to accounts, so far as applicable to the company.
These accounts have been prepared in accordance with the provisions applicable to small companies subject to the small companies’ regime and in accordance with FRS102 SORP.
25/10/22
Approved on and signed on behalf of all directors by:
Mr P Trill Director
Company Number: 12447230
5
CURE CLCN4 (a company limited by guarantee)
Notes forming part of the accounts for the year ended 31 December 2021
1 BASIS OF PREPARATION
Cure CLCN4 is a company limited by guarantee incorporated in England and Wales.
The financial statements have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK (FRS 102) (effective 1 January 2015), the Financial Reporting Standard applicable in the UK (FRS 102), the Companies Act 2006 and the Charities Act 2011.
The Charity constitutes a public benefit entity as defined by FRS 102.
The accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant notes to these accounts.
2 ACCOUNTING POLICIES
2.1 Incoming resources
All income is recognised once the charity has entitlement to the income, there is sufficient certainty of receipt and so it is probable that the income will be received, and the amount of income received can be measured reliably.
2.2 Offsetting
There has been no offsetting of assets and liabilities, or income and expenses, unless required or permitted by the FRS 102 SORP or FRS 102.
2.3 Grants and donations
Grants and donations are only included in the SoFA when the general income recognition criteria are met (5.10 to 5.12 FRS102 SORP).
2.4 Direct charitable resources expended
Direct charitable expenditure includes the direct costs in furtherance of the charity’s objectives and are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of obligation can be measured reliably. Expenditure is accounted for under the accruals concept.
2.5 Administration resources expended
Administration costs represent the running costs of the charity and are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of obligation can be measured reliably. Expenditure is accounted for under the accruals concept.
6
CURE CLCN4 (a company limited by guarantee)
Notes forming part of the accounts for the period ended 31 December 2021 (continued)
3 Income from donations
| Individual donations 4 Expenditure Expenditure on charitable activities Staff Wages Staff pension Conferences Research costs Processing fees Computer expenses Accountancy Consultancy Advertising Legal & Professional 5 Cash at bank and in hand Cash at bank and on hand 6 Debtors Amounts due from social platforms |
2021 £ 119,158 119,158 2021 £ - 18,793 1,139 35 5,055 528 287 1,816 6,248 (291) - 33,610 2021 £ 77,628 77,628 2021 £ 2,120 2,120 |
2020 £ - |
|---|---|---|
| - | ||
| 2020 £ - - - - - - - - 1,450 7,098 |
||
| 8,548 | ||
| 2020 £ 2,890 |
||
| 2,890 | ||
| 2020 £ - |
||
| - |
7
CURE CLCN4 (a company limited by guarantee)
Notes forming part of the accounts for the period ended 31 December 2021 (continued)
7 Creditors: amounts falling due within one year
| Accruals PAYE & Pension Loan from director |
2021 £ 1,816 932 11,438 14,186 |
2020 £ - - 11,438 |
|---|---|---|
| 11,438 |
8 Funds of the Company
All funds held by the company are unrestricted and are to be used in the furtherance of the company’s objectives as outlined in the directors’ report on page 2.
9 Related party transactions and Trustees’ Remuneration and expenses
During the year P Trill donated £87,500 to the company. P Trill is a director and trustee of Cure CLCN4.
The trustees all give freely their time and expertise without any form of remuneration or other benefit in cash or kind. None of the trustees were paid expenses during the year.
8
Lewin Accounts Ltd/Chartered Accountant Independent examiner's report to the Trustees of Cure CLCN4 Ltd Registered Charity England and Wale5, No. 1190344, Company number 12447230 I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2021. Responsibilitles and basis of report As the charity trustees of the Company Iwho are also the directors of the company for the purposes of company lawl, you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 20061"the 2006 Act"). Having satisfied myself that the accounts of the Company are not required to be audlted for thls year under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 20111"the 2011 Act"). In carrying out my examination, I have followed the Directions 8iven by the Charity Commission (under section 14515llbl of the 2011 Act. Independent examinerfs statement I have completed my examination. I confirm that no material matters have come to my attention which gives me cause to believe that.. 3ccountin8 records were not kept in accordance with section 386 of the Companie5 Act 2006; or the accounts do not accord with such records; or the accounts do not comply with relevant accounting requirements under section 396 of the Companies Act 2006 other than any requirement that the accounts give a "true and fair" view which is not a matter considered as part of the independent examination; or the accounts have not been prepared in accordance with the Charities SORP IFRS 1021 I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Colin Lewin, FCA Mercury House 19-21 Chapel Street Marlow Bucks. SL7 3HN 25 October 2022 Phone.. 01628 890504 Email.. colin@lewinaccoLJnts.co.uk Registered office: Mercury House 19-21 Chapel St Marlow Buck5 SL7 3HN Registered in England No 7197950